Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers

Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux

Status: Completed

Conditions: Covid-19 Immune Status of Healthcare Workers

Treatments: Diagnostic Test: AAZ Covid-19 rapid test

Study type: Interventional

Funder types: NETWORK

Identifiers

NCT04525417

GERES20200409

ID RCB 2020-A01031-38 (Other Identifier)

Details and patient eligibility

About

The study objectives were to assess 1/the immune status of healthcare professionals with suggestive symptomatology of Covid-19 infection and 2/the sensitivity and specificity of AAZ rapid test by comparing it with a serological ELISA test.

An open-label, monocentric, prospective, non-randomized study, is conducted, including 50 hospital healthcare professionals and 50 private health professionals.

Knowledge of serostatus will achieve the implementation of a strategy of management of patients according to specific immunity of health professionals

Enrollment: 75 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Healthcare professionals with symptoms suggestive of Covid-19 infection

Exclusion criteria

• any other subject
• pregnant women
• protected adult

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

75 participants in 2 patient groups

hospital healthcare workers

Other group

Description:

Clinical examination; Veinous blood sampling for serological testing; capillary drawing to perform a rapid Covid-19 test

Treatment:

Diagnostic Test: AAZ Covid-19 rapid test

private health professionals

Other group

Description:

Clinical examination; Veinous blood sampling for serological testing; capillary drawing to perform a rapid Covid-19 test

Treatment:

Diagnostic Test: AAZ Covid-19 rapid test